A new insight into resveratrol as an atheroprotective compound: Inhibition of lipid peroxidation and enhancement of cholesterol efflux

Superko, 1989, Drug therapy and the prevention of atherosclerosis in humans, Am J Cardiol, 64, 31G, 10.1016/0002-9149(89)90953-3 Das, 2007, Resveratrol: a therapeutic promise for cardiovascular diseases, Recent Patents Cardiovasc Drug Discov, 2, 133, 10.2174/157489007780832560 Norata, 2007, Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice, Atherosclerosis, 191, 265, 10.1016/j.atherosclerosis.2006.05.047 Wang, 2005, Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels, Int J Mol Med, 16, 533 Araya, 2001, Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes, Br J Nutr, 86, 189, 10.1079/BJN2001369 Auger, 2002, Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters (Mesocricetus auratus), J Nutr, 132, 1207, 10.1093/jn/132.6.1207 Belguendouz, 1997, Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins, Biochem Pharmacol, 53, 1347, 10.1016/S0006-2952(96)00820-9 Wang, 2002, Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro, Int J Mol Med, 9, 77 Araim, 2002, Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols, J Vasc Surg, 35, 1226, 10.1067/mva.2002.124358 Avellone, 2006, Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis, Eur J Clin Nutr, 60, 41, 10.1038/sj.ejcn.1602265 Sevov, 2006, Resveratrol regulates the expression of LXR-alpha in human macrophages, Biochem Biophys Res Commun, 348, 1047, 10.1016/j.bbrc.2006.07.155 Lusis, 2000, Nature, 407, 233, 10.1038/35025203 Aviram, 1994, Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor, J Lipid Res, 35, 385, 10.1016/S0022-2275(20)41191-5 Cherki, 2007, Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging, Exp Gerontol, 42, 815, 10.1016/j.exger.2007.04.006 Glomset, 1968, The plasma lecithins:cholesterol acyltransferase reaction, J Lipid Res, 9, 155, 10.1016/S0022-2275(20)43114-1 Bortnick, 2000, The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines, J Biol Chem, 275, 28634, 10.1074/jbc.M003407200 de La Llera-Moya, 2001, Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL, J Lipid Res, 42, 1969, 10.1016/S0022-2275(20)31525-X Wang, 2000, Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1, J Biol Chem, 275, 33053, 10.1074/jbc.M005438200 Brunham, 2006, Intestinal ABCA1 directly contributes to HDL biogenesis in vivo, J Clin Invest, 116, 1052, 10.1172/JCI27352 Kennedy, 2005, ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation, Cell Metab, 1, 121, 10.1016/j.cmet.2005.01.002 Zou, 2000, Effects of resveratrol on oxidative modification of human low density lipoprotein, Chin Med J (Engl), 113, 99 Fremont, 1999, Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids, Life Sci, 64, 2511, 10.1016/S0024-3205(99)00209-X Mensor, 2001, Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method, Phytother Res, 15, 127, 10.1002/ptr.687 Sattler, 1994, Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence, Methods Enzymol, 233, 469, 10.1016/S0076-6879(94)33053-0 Khalil, 2000, Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation, J Lipid Res, 41, 1552, 10.1016/S0022-2275(20)31987-8 Fricke, 1927, The chemical action of Röntgen rays on dilute ferrosulfate solutions as measure of dose, Am J Roentgenol Radium Ther Nucl Med, 18, 429 Berrougui, 2006, Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages, Atherosclerosis, 184, 389, 10.1016/j.atherosclerosis.2005.05.018 Pinchuk, 2002, The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments, Prog Lipid Res, 41, 279, 10.1016/S0163-7827(01)00026-1 Linton, 1995, Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation, Science, 267, 1034, 10.1126/science.7863332 Hajj Hassan, 2005, Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release, J Lipid Res, 46, 1457, 10.1194/jlr.M400477-JLR200 Berrougui, 2007, Age-related impairment of HDL-mediated cholesterol efflux, J Lipid Res, 48, 328, 10.1194/jlr.M600167-JLR200 Bonnefont-Rousselot, 2004, Gamma radiolysis as a tool to study lipoprotein oxidation mechanisms, Biochimie, 86, 903, 10.1016/j.biochi.2004.10.007 Marcil, 2006, Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors, Cardiovasc Res, 72, 473, 10.1016/j.cardiores.2006.08.024 Girona, 2003, HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages, Biochim Biophys Acta, 1633, 143, 10.1016/S1388-1981(03)00108-2 Gugliucci, 2002, Three different pathways for human LDL oxidation are inhibited in vitro by water extracts of the medicinal herb Achyrocline satureoides, Life Sci, 71, 693, 10.1016/S0024-3205(02)01734-4 Kaliora, 2006, Dietary antioxidants in preventing atherogenesis, Atherosclerosis, 187, 1, 10.1016/j.atherosclerosis.2005.11.001 Xu, 2007, Comparative studies on the antioxidant activities of nine common food legumes against copper-induced human low-density lipoprotein oxidation in vitro, J Food Sci, 72, S522, 10.1111/j.1750-3841.2007.00464.x Tunstall-Pedoe, 1999, Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease, Lancet, 353, 1547, 10.1016/S0140-6736(99)04021-0 Tsai, 1999, Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol, Br J Pharmacol, 126, 673, 10.1038/sj.bjp.0702357 de Lorgeril, 2000, Diet as preventive medicine in cardiology, Curr Opin Cardiol, 15, 364, 10.1097/00001573-200009000-00009 Haberland, 1988, Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits, Science, 241, 215, 10.1126/science.2455346 Regnstrom, 1992, Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man, Lancet, 339, 1183, 10.1016/0140-6736(92)91129-V Heinecke, 1998, Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis, Atherosclerosis, 141, 1, 10.1016/S0021-9150(98)00173-7 Belguendouz, 1998, Interaction of transresveratrol with plasma lipoproteins, Biochem Pharmacol, 55, 811, 10.1016/S0006-2952(97)00544-3 Zini, 1999, Effects of resveratrol on the rat brain respiratory chain, Drugs Exp Clin Res, 25, 87 Fredenrich, 2003, Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data, Diab Metab, 29, 201, 10.1016/S1262-3636(07)70029-0 Jaouad, 2003, PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity, Free Radic Res, 37, 77, 10.1080/1071576021000036614 Pirillo, 2006, 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages, Biochim Biophys Acta, 1761, 292, 10.1016/j.bbalip.2006.03.009 Oram, 2005, ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease, Physiol Rev, 85, 1343, 10.1152/physrev.00005.2005 Vaughan, 2003, ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions, J Lipid Res, 44, 1373, 10.1194/jlr.M300078-JLR200 Tsang, 2005, The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers, Br J Nutr, 93, 233, 10.1079/BJN20041311 Francis, 2000, High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences, Biochim Biophys Acta, 1483, 217, 10.1016/S1388-1981(99)00181-X Panzenboeck, 1997, Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins, J Biol Chem, 272, 29711, 10.1074/jbc.272.47.29711 Trudel, 2005, Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats, J Cell Biochem, 96, 404, 10.1002/jcb.20542 Ferretti, 2006, Structural modifications of HDL and functional consequences, Atherosclerosis, 184, 1, 10.1016/j.atherosclerosis.2005.08.008 Rifici, 1996, Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages, Biochim Biophys Acta, 1299, 87, 10.1016/0005-2760(95)00198-0